http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2654701-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d4fc32a5a30ede545770ac85df21d06
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-71
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2017-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96e19ee9eac8a300999d57edecb27025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f84413570c290845fb0874d31fccac13
publicationDate 2018-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2654701-C1
titleOfInvention Method for treating malignant neoplasms
abstract FIELD: medicine. n SUBSTANCE: invention relates to medicine, namely to oncourology, and can be used to treat and prevent the recurrence of malignant neoplasms of the lower urinary tract. For this purpose, celandine juice in a dilution of 1:1 with a 0.9 % NaCl solution in an amount of 20 ml with the addition of 1.0 ml of dimexide is used as an agent for introduction into a urinary bladder for the treatment of said pathology. n EFFECT: method for treating malignant neoplasms is proposed. n 1 cl, 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2747637-C1
priorityDate 2017-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2123827-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012136829-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2352359-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002086390-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2493846-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID13329
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID71251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1257693
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3483
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID112591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10569
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID308558
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID46901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558503
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID41956
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID90345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551813
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID90345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416115248
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID41956
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527046
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID71251
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID308558
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID98504
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID65561
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2713
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID98504
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID65561
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID46901
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID13329
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3483
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID112591

Total number of triples: 56.